Michael Chobotov - TriVascular Technologies Insider

TriVascular Technologies Inc -- USA Stock  

USD 5.87  0.56  10.55%

Co-Founder and CTO

Dr. Michael V. Chobotov Ph.D. is CoFounder Chief Technology Officer of TriVascular Technologies Inc. He currently serves as our Chief Technology Officer and served as a member of our Board until April 2014. Prior to cofounding TriVascular in 1998 Dr. Chobotov cofounded TransMotive Technologies an engineering and product development consulting company. Previously Dr. Chobotov served as Senior Vice President of RD and board member of U.S. Electricar and Senior Systems Engineer at Hughes Space and Communications. He also led the design of the Lunar Prospector which was subsequently implemented as the first NASA Discovery mission
Age: 53  Founder Since 2014      
707-543-8800  http://www.trivascular.com
Chobotov received his Ph.D. in Mechanical Engineering, his M.S. in Mechanical Engineering and his B.S. in Engineering and Applied Science, all from the California Institute of Technology.

Michael Chobotov Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (0.57) % which means that it has lost $0.57 on every $100 spent on asset. This is way below average.
The company currently holds 55 M in liabilities with Debt to Equity (D/E) ratio of 1.74 which is about average as compared to similar companies. TriVascular Technologies Inc has Current Ratio of 6.98 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms . TriVascular Technologies Inc (TRIV) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 307 people. TriVascular Technologies is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  Next  Launch Portfolio Rebalancing
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add TriVascular Technologies Inc to your portfolio

Top Management

TriVascular Technologies Leadership Team
Jake Nunn, Director, CFA
Christopher Chavez, Chairman, MBA
Ryan Drant, Director
Michael Kramer, CFO
Kimberley Elting, VP
Daniel Moore, Director, MBA
James Scopa, Director, MBA
Vivek Jayaraman, President, MBA
Louis Molinari, President
Robert Whirley, Founder
Robert Thomas, Director
Michael Chobotov, Founder
Douglas Roeder, Director
Shari OQuinn, President

Stock Performance

TriVascular Technologies Performance Indicators